Clinical Trial Data for Cesarean Scar Pregnancy Treatments in China, 2018-2019

151 patients with stable cesarean scar pregnancy (CSP) were treated at three hospitals in China from June 2018 to December 2019. This retrospective analysis compares the efficacy, safety, and cost of ultrasound-guided local lauromacrogol injection (USG-LLI) versus uterine artery embolization (UAE), both combined with curettage and hysteroscopy. The dataset was authored by Qing Wu and is available via paperswithcode.

Use Cases

• Compare treatment efficacy rates between USG-LLI and UAE based on the success rates mentioned in the description.
• Analyze complication rates between the two treatment groups based on the reported 5.81% and 24.62% figures.
• Model cost differences in medical care based on the total, non-medication, and direct medical costs reported.
• Study patient outcomes for minimally invasive CSP treatments based on the clinical characteristics and results described.

Strengths

• Includes data from 151 patients across three hospitals, providing a multi-center perspective.
• Compares two distinct treatment protocols (USG-LLI and UAE) with clear outcome measures for efficacy, safety, and cost.
• Reports statistically significant differences in complication rates (5.81% vs 24.62%) and costs between the two groups.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for specific modeling tasks.
• Data may reflect geographic and temporal bias inherent to the specific hospitals and time period studied.

Provenance

Source

Qing Wu, via paperswithcode.

Collection Method

Retrospective analysis of patient records.

Time Range

June 2018 to December 2019.

Freshness

Last update date is unknown; freshness unverified.

Geography

Three hospitals in China.